PolyPid Stock

PolyPid ROA

The Return on Assets (ROA) of PolyPid (PYPD) as of Sep 4, 2026 is -153.18 %. In the previous year, Return on Assets (ROA) was -115.08 % — a change of 33.11% (lower).

ROA

-153.18 %

YoY

33.11%

Last updated:

In 2026, PolyPid's return on assets (ROA) was -153.18 %, a 33.11% increase from the -115.08 % ROA in the previous year.

The PolyPid ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2018
40.85 USD
Jan 1, 2019
-20.45 USD
Jan 1, 2020
-46.57 USD
Jan 1, 2021
-92.04 USD
Jan 1, 2022
-152.19 USD
Jan 1, 2023
-155.25 USD
Jan 1, 2024
-115.08 USD
Jan 1, 2025
-153.18 USD
The PolyPid ROA history
YEARROAYoY
-153.18 %+33.11%
-115.08 %-25.88%
-155.25 %+2.01%
-152.19 %+65.35%
-92.04 %+97.62%
-46.57 %+127.74%
-20.45 %-150.06%
40.85 %-117.23%
-237.07 %+300.32%
-59.22 %-82.13%
-331.45 %
Access this data via the Eulerpool API

PolyPid Stock analysis

What does PolyPid do? PolyPid Ltd is an innovative, emerging company in the field of biomedical technology based in Israel. The company was founded in 2008 and has since gained continuous recognition and growth. PolyPid's core business is the development and manufacturing of implantable polymer systems that contribute to wound healing. These polymer systems are specifically introduced into the affected area of the body and continuously release active substances to prevent infections and promote natural healing processes. PolyPid's business model is focused on effectively solving patients' problems. The company has developed a wide range of products and technologies that specifically target various medical applications. These include orthopedics, traumatology, urology, and gynecology. For orthopedics, PolyPid provides various products and technologies that can be used in knee and hip joint surgeries. These include antibiotic-releasing implants to prevent infections and resorbable bone fillers that allow for faster and more effective wound healing. In the field of traumatology, PolyPid manufactures polymer systems that are used in the treatment of bone fractures or other traumas. Here again, the polymer systems ensure continuous release of active substances to prevent infections and promote natural healing processes. PolyPid also offers innovative solutions for urology. Specifically, products are developed to combat urinary tract infections and promote faster wound healing after urological surgeries. For gynecology, PolyPid offers polymer systems that can be used particularly in the postoperative phase to prevent infections and achieve faster wound healing. PolyPid has earned an excellent reputation in the industry in recent years due to its consistent focus on innovation and quality. To continually improve their products, the company invests heavily in research and development and maintains close contact with medical institutions and professionals worldwide. PolyPid is an important partner in the field of biomedical technology and has already received numerous awards for its groundbreaking products and developments. Thanks to its focus on quality, reliability, and innovation, the company will continue to play a key role in the biomedical technology market. PolyPid is one of the most popular companies on Eulerpool.

ROA Details

Understanding PolyPid's Return on Assets (ROA)

PolyPid's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing PolyPid's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider PolyPid's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in PolyPid’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about PolyPid stock

Return on Assets (ROA) of PolyPid is -153.18 % in 2026.

Return on Assets (ROA) of PolyPid changed from -115.08 % to -153.18 %, representing a 33.11% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) PolyPid since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s PolyPid with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

Profitability — PolyPid

All Key Metrics — PolyPid